How to Save Money on Retacrit in 2026: Coupons, Discounts, and Patient Assistance

Retacrit (epoetin alfa-epbx) is a specialty biologic — and with that comes a hefty price tag. Depending on the vial strength and your monthly dose, the cash price of Retacrit can range from a few hundred to several thousand dollars per month. The good news: most patients who need Retacrit have coverage options, and Pfizer offers patient assistance for those who don't. Here's a complete breakdown of your savings options in 2026.

What Does Retacrit Cost Without Insurance?

Cash prices for Retacrit vary significantly by vial strength:

• 2,000 Units/mL (10 mL vial): approximately $228–$250 per vial
• 4,000 Units/mL (10 mL vial): approximately $449–$480 per vial
• 10,000 Units/mL (10 mL single-dose vial): approximately $1,112–$1,200 per vial
• 40,000 Units/mL (1 mL single-dose vial): retail approximately $560 per vial; SingleCare coupon price approximately $442

Because patients may need multiple vials per week depending on their dose (e.g., a patient on 10,000 Units 3x/week uses 3 vials weekly), monthly costs without insurance can easily exceed $3,000–$13,000 for higher-dose protocols. However, the vast majority of Retacrit patients have some form of insurance coverage.

Option 1: Medicare Part B Coverage

For many Retacrit patients — particularly those with CKD on dialysis — the drug is covered under Medicare Part B (not Part D), since it's typically administered in a medical setting. Under Part B, Medicare pays 80% of the approved amount, and you pay 20% after the annual deductible ($257 in 2025). If you have a Medigap supplement, that 20% coinsurance may be covered as well.

For home self-injection patients billed under Part D, Retacrit coverage varies by plan. Some Part D plans do not cover Retacrit since it is often classified as a medical benefit drug — check with your plan before assuming it's covered under your pharmacy benefit.

Option 2: Commercial Insurance with Prior Authorization

Most commercial health insurance plans cover Retacrit for its approved indications, but require prior authorization. Key facts:

• Many plans have made Retacrit their preferred ESA over Epogen/Procrit due to its lower acquisition cost — this means your copay may be lower with Retacrit than with brand-name alternatives
• Typical copays for covered specialty biologics range from $0–$150/month depending on your plan tier and out-of-pocket maximum
• When billed under the medical benefit (administered by a provider), you typically pay your plan's coinsurance (often 10–20%) after meeting your deductible

Option 3: Pfizer Oncology Together Patient Assistance Program

Pfizer offers a Patient Assistance Program (PAP) for Retacrit through Pfizer RxPathways. Eligible patients who are uninsured or underinsured may receive Retacrit at no cost. Key details:

• Program name: Pfizer Oncology Together / Pfizer RxPathways
• Phone: 1-877-744-5675
• Website: pfizerrxpathways.com
• Eligibility: Primarily patients without insurance or with limited incomes; some insured and Medicare Part D patients may qualify under specific criteria
• Application: Available online at pfizerrxpathways.com or by phone; your prescriber may need to sign the application

Option 4: Prescription Discount Cards (Limited Use for Retacrit)

Discount cards like SingleCare or GoodRx can reduce the cash price of Retacrit at participating specialty pharmacies. SingleCare's listed price for a 40,000 Units/mL 1 mL vial is approximately $442 (vs. a retail price of ~$560). However, these savings are most useful for patients paying out-of-pocket — if you have insurance, using your coverage is typically more cost-effective.

Important: Prescription discount cards cannot be used simultaneously with insurance, Medicare, or Medicaid.

Option 5: State Pharmaceutical Assistance Programs and Foundations

If you don't qualify for Pfizer's PAP, consider:

• NeedyMeds.org: Comprehensive database of patient assistance programs and disease-specific foundations
• American Kidney Fund: Offers copay assistance for CKD patients on dialysis, which may cover out-of-pocket costs for ESA therapy
• CancerCare Co-Payment Assistance Foundation: For cancer patients receiving Retacrit for chemotherapy-induced anemia
• State Medicaid: If your income qualifies, Medicaid typically covers Retacrit with minimal or no out-of-pocket cost

The Bottom Line

Retacrit is expensive, but most patients have coverage options that significantly reduce out-of-pocket costs. If you're uninsured or struggling with costs, Pfizer's RxPathways program is your best first call. And if you're struggling to find Retacrit at a pharmacy, medfinder can help locate pharmacies with your specific strength in stock. See our guide on how to find Retacrit in stock near you for practical access tips.